Abstracts tagged "prevention"

Abstract Number: 1577 • 2012 ACR/ARHP Annual Meeting
Barriers to Recruit Unaffected Family Members of Patients with Rheumatoid Arthritis
Axel Finckh¹, A. Debost-Legrand², Martin Soubrier³, I. von Muehlenen⁴, I. Creveaux², JJ Dubost³, MH Papon², H. Ayadi⁵, P. Migliorini⁶, E. Petit-Teixeira⁷, F. Cornélis² and Eprac⁸, ¹Rheumatology, Geneva University Hospitals, Geneva 14, Switzerland, ²GenHotel-Auvergne, Clermon-Ferrand, France, ³Rheumatology, CHU CLERMONT-FERRAND, Clermont-Ferrand, France, ⁴Rheumatology, Universitäts-Poliklinik, Felix-Platter Spital, Basel, Switzerland, ⁵Sfax university, Sfax, Tunisia, ⁶Pisa university hospital, Pisa, Italy, ⁷GenHotel-Evry-EA3886, Evry, France, ⁸(European pre-RA consortium), Clermont-Ferrand, France
Background/Purpose: Prospective studies are needed to answer key questions on rheumatoid arthritis (RA) screening in at risk populations : (1) How accurately does risk factor…
Abstract Number: 655 • 2012 ACR/ARHP Annual Meeting
Non-White Race, Younger Age, and Use of Primary and Gynecologic Care Are Associated with Higher Rates of Cervical Cancer Screening in Systemic Lupus Erythematosus Patients At a Public Hospital
Jennifer Stichman¹, Angela Keniston², Joann Zell³, Jinoos Yazdany⁴, Itziar Quinzanos¹ and Joel M. Hirsh⁵, ¹Dept Medicine, Denver Health Med Ctr, Denver, CO, ²Department of Medicine, Denver Health and Hospital Authority, Denver, CO, ³Medicine, National Jewish Health, Denver, CO, ⁴Medicine, University of California, San Francisco, San Francisco, CA, ⁵Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO
Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) are at increased risk of cervical dysplasia and persistent Human Papilloma Virus (HPV) infection. There are few prior…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].